World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
31518
World Ranking
13548
National Ranking
6890

Overview

Shreyaskumar Patel is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the field of Medicine, with a specialization spanning several subfields such as Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, and Rheumatology.

The scientist's main topics of work concentrate on Sarcoma Diagnosis and Treatment, Cardiac tumors and thrombi, Vascular Tumors and Angiosarcomas, Bone Tumor Diagnosis and Treatments, CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, and Gastrointestinal Tumor Research and Treatment.

Frequent publication venues for their work include:

  • Journal of Clinical Oncology
  • Cancers
  • Annals of Oncology
  • Clinical Cancer Research
  • Cancer

Some notable recent papers by Shreyaskumar Patel are:

  • Immuno-genomic landscape of osteosarcoma, 2020, Nature Communications
  • Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities, 2021, Cancer
  • Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network, 2020, Annals of Oncology
  • Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial, 2022, The Lancet Oncology
  • Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study, 2021, Journal of Clinical Oncology

Frequent co-authors collaborating with Patel include:

  • Anthony P. Conley
  • Alexander J. Lazar
  • Neeta Somaiah
  • J. Andrew Livingston
  • Ravin Ratan

Overall, the research profile of Shreyaskumar Patel reveals extensive engagement in oncology and related medical fields, especially focusing on tumor diagnosis and treatment modalities. Their work spans clinical, pathological, and therapeutic aspects of cancer subtypes, with a body of publications present in key oncology and cancer research outlets.

Best Publications

  • Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria

    Haesun Choi;Chuslip Charnsangavej;Silvana C. Faria;Homer A. Macapinlac

  • Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

    Ronald P. DeMatteo;Karla V. Ballman;Cristina R. Antonescu;Robert G. Maki

  • A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group.

    Charles G. Fisher;Christian P. Dipaola;Timothy C. Ryken;Mark H. Bilsky

  • Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

    Hussein A Tawbi;Melissa Burgess;Vanessa Bolejack;Brian A Van Tine

  • Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas

    Robert G. Maki;J. Kyle Wathen;Shreyaskumar R. Patel;Dennis A. Priebat

  • Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

    George D. Demetri;Margaret von Mehren;Robin L. Jones;Martee L. Hensley

  • Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

    Patrick Schöffski;Sant Chawla;Robert G. Maki;Antoine Italiano

  • We Should Desist Using RECIST, at Least in GIST

    Robert S. Benjamin;Haesun Choi;Homer A. Macapinlac;Michael A. Burgess

  • Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.

    Gunar K. Zagars;Matthew T. Ballo;Peter W. T. Pisters;Raphael E. Pollock M.D.

  • Spinal Instability Neoplastic Score: An Analysis of Reliability and Validity From the Spine Oncology Study Group

    Daryl R. Fourney;Evan M. Frangou;Timothy C. Ryken;Christian P. DiPaola

  • Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: Primary tumor size and primary tumor location as prognostic indicators

    Montserrat Ayala-Ramirez;Lei Feng;Marcella M. Johnson;Shamim Ejaz

  • A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

    Lei L. Chen;Jonathan C. Trent;Elsie F. Wu;Gregory N. Fuller

  • R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

    Alberto S. Pappo;Shreyaskumar R. Patel;John Crowley;Denise K. Reinke

  • Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution.

    Charles A. Portera;Viet Ho;Shreyaskumar R. Patel;Kelly K. Hunt

  • Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib

    Robert H. I. Andtbacka;Chaan S. Ng;Courtney L. Scaife;Janice N. Cormier

  • Phase II Clinical Investigation of Gemcitabine in Advanced Soft Tissue Sarcomas and Window Evaluation of Dose Rate on Gemcitabine Triphosphate Accumulation

    Shreyaskumar R. Patel;Varsha Gandhi;Jan Jenkins;Nicholas Papadopolous

  • Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

    Christopher L. Corless;Karla V. Ballman;Cristina R. Antonescu;Violetta Kolesnikova

  • High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.

    S R Patel;S Vadhan-Raj;N Papadopolous;C Plager

  • Optimizing Treatment of Desmoid Tumors

    Dina Lev;Dhanasekaran Kotilingam;Caimiao Wei;Matthew T. Ballo

  • Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer.

    Saroj Vadhan-Raj;Lesley J. Murray;Carlos Bueso-Ramos;Shreyaskumar Patel

Frequent Co-Authors

Robert S. Benjamin
Robert S. Benjamin The University of Texas MD Anderson Cancer Center
Raphael E. Pollock
Raphael E. Pollock The Ohio State University
Robert G. Maki
Robert G. Maki University of Pennsylvania
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
Peter W.T. Pisters
Peter W.T. Pisters The University of Texas MD Anderson Cancer Center
George D. Demetri
George D. Demetri Dana-Farber Cancer Institute
Margaret von Mehren
Margaret von Mehren Fox Chase Cancer Center
Gunar K. Zagars
Gunar K. Zagars The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to traditional MD routes. There are a range of related online degrees and certifications that offer flexibility and diverse healthcare career pathways. For example, nurses can advance their studies affordably through cheapest bsn to dnp programs, gaining advanced clinical and leadership skills while studying remotely.

Prospective pharmacists can explore pharmacy school online accredited options, which provide pathways to a Doctor of Pharmacy degree through rigorous yet convenient online programs. These accredited programs are vital for ensuring eligibility for licensure.

Not all healthcare roles require direct patient care. A bachelor of health information management online opens doors to data management and healthcare administration—a growing field as digital records become standard.

Those interested in the administrative side can consider medical coding and billing. Understanding medical billing and coding certification cost helps learners find cost-effective ways to enter this in-demand career.

Best Scientists Citing Shreyaskumar Patel

Trending Scientists

Recently Published Articles